​

BioRestorative Therapies (BRTX) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

BioRestorative Therapies Revenue Highlights

Latest Revenue (Y)

$401.00K

Latest Revenue (Q)

$233.60K

Main Segment (Y)

Product

BioRestorative Therapies Revenue by Period

BioRestorative Therapies Revenue by Year

DateRevenueChange
2024-12-31$401.00K175.03%
2023-12-31$145.80K21.70%
2022-12-31$119.80K160.43%
2021-12-31$46.00K-40.26%
2020-12-31$77.00K-40.77%
2019-12-31$130.00K17.12%
2018-12-31$111.00K37.04%
2017-12-31$81.00K122.80%
2016-12-31$36.35K-94.22%
2015-12-31$628.91K51.18%
2014-12-31$416.00K24661.67%
2013-12-31$1.68K-89.22%
2012-12-31$15.59K100.00%
2011-12-31-100.00%
2010-12-31--

BioRestorative Therapies generated $401.00K in revenue during NA 2024, up 175.03% compared to the previous quarter, and up 308.46% compared to the same period a year ago.

BioRestorative Therapies Revenue by Quarter

DateRevenueChange
2024-09-30$233.60K162.18%
2024-06-30$89.10K154.57%
2024-03-31$35.00K81.35%
2023-12-31$19.30K-37.13%
2023-09-30$30.70K-52.40%
2023-06-30$64.50K106.07%
2023-03-31$31.30K745.95%
2022-12-31$3.70K-87.24%
2022-09-30$29.00K-59.21%
2022-06-30$71.10K344.38%
2022-03-31$16.00K220.00%
2021-12-31$5.00K-37.50%
2021-09-30$8.00K-46.67%
2021-06-30$15.00K-16.67%
2021-03-31$18.00K5.88%
2020-12-31$17.00K13.33%
2020-09-30$15.00K-21.05%
2020-06-30$19.00K-26.92%
2020-03-31$26.00K-18.75%
2019-12-31$32.00K-15.79%
2019-09-30$38.00K22.58%
2019-06-30$31.00K6.90%
2019-03-31$29.00K-
2018-12-31$29.00K11.54%
2018-09-30$26.00K-29.73%
2018-06-30$37.00K94.74%
2018-03-31$19.00K-50.00%
2017-12-31$38.00K137.50%
2017-09-30$16.00K-20.00%
2017-06-30$20.00K185.71%
2017-03-31$7.00K15.23%
2016-12-31$6.08K21.50%
2016-09-30$5.00K-69.05%
2016-06-30$16.16K77.04%
2016-03-31$9.13K-95.42%
2015-12-31$199.13K107.16%
2015-09-30$96.12K-35.39%
2015-06-30$148.76K-19.54%
2015-03-31$184.90K131.85%
2014-12-31$79.75K-50.13%
2014-09-30$159.93K-9.10%
2014-06-30$175.94K46817.60%
2014-03-31$375.00100.00%
2013-12-31--100.00%
2013-09-30$125.00-70.59%
2013-06-30$425.00-62.39%
2013-03-31$1.13K210.44%
2012-12-31$364.00-93.03%
2012-09-30$5.22K-47.75%
2012-06-30$10.00K100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30--

BioRestorative Therapies generated $233.60K in revenue during Q3 2024, up 162.18% compared to the previous quarter, and up 362.17% compared to the same period a year ago.

BioRestorative Therapies Revenue Breakdown

BioRestorative Therapies Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Royalty$101.00K
Product$300.00K

BioRestorative Therapies's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (74.81%), and Royalty (25.19%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Jun 24
Royalty$78.30K$2.90K$19.80K
Product-$230.70K$69.30K

BioRestorative Therapies's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Royalty (100.00%).

BioRestorative Therapies Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CAPRCapricor Therapeutics$22.27M$2.26B
PULMPulmatrix$7.81M$366.00K
SABSSAB Biotherapeutics$2.24M$263.14K
BRTXBioRestorative Therapies$401.00K$233.60K
ANEBAnebulo Pharmaceuticals--
BPTHBio-Path--
CADLCandel Therapeutics--
SLNOSoleno Therapeutics--
XTLBXTL Biopharmaceuticals--
CINGCingulate--
AKTXAkari Therapeutics--
CVKDCadrenal Therapeutics--
ACHVAchieve Life Sciences--
MNPRMonopar Therapeutics--

BRTX Revenue FAQ

What is BioRestorative Therapies’s yearly revenue?

BioRestorative Therapies's yearly revenue for 2024 was $401K, representing an increase of 175.03% compared to 2023. The company's yearly revenue for 2023 was $145.8K, representing an increase of 21.70% compared to 2022. BRTX's yearly revenue for 2022 was $119.8K, representing an increase of 160.43% compared to 2021.

What is BioRestorative Therapies’s quarterly revenue?

BioRestorative Therapies's quarterly revenue for Q3 2024 was $233.6K, a 162.18% increase from the previous quarter (Q2 2024), and a 660.91% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $89.1K, a 154.57% increase from the previous quarter (Q1 2024), and a 38.14% increase year-over-year (Q2 2023). BRTX's quarterly revenue for Q1 2024 was $35K, a 81.35% increase from the previous quarter (Q4 2023), and a 11.82% increase year-over-year (Q1 2023).

What is BioRestorative Therapies’s revenue growth rate?

BioRestorative Therapies's revenue growth rate for the last 3 years (2022-2024) was 234.72%, and for the last 5 years (2020-2024) was 420.78%.

What are BioRestorative Therapies’s revenue streams?

BioRestorative Therapies's revenue streams in c 24 are Royalty, and Product. Royalty generated $101K in revenue, accounting 25.19% of the company's total revenue Product generated $300K in revenue, accounting 74.81% of the company's total revenue

What is BioRestorative Therapies’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of BioRestorative Therapies was Product. This segment made a revenue of $300K, representing 74.81% of the company's total revenue.